These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 25630622)
1. β1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection. Liu Y; Liu H; Liu W; Zhang W; An H; Xu J World J Urol; 2015 Nov; 33(11):1791-9. PubMed ID: 25630622 [TBL] [Abstract][Full Text] [Related]
2. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma. Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma. Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329 [TBL] [Abstract][Full Text] [Related]
4. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma. Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202 [TBL] [Abstract][Full Text] [Related]
5. p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma. Zhu Y; Xu L; An H; Liu W; Wang Z; Xu J Int J Urol; 2015 May; 22(5):447-53. PubMed ID: 25711487 [TBL] [Abstract][Full Text] [Related]
6. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma. Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma. Yang L; Wu Q; Xu L; Zhang W; Zhu Y; Liu H; Xu J; Gu J BMC Cancer; 2015 Feb; 15():67. PubMed ID: 25886010 [TBL] [Abstract][Full Text] [Related]
8. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma. Laba P; Wang J; Zhang J BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799 [TBL] [Abstract][Full Text] [Related]
9. Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection. Fu Q; Liu Z; Pan D; Zhang W; Xu L; Zhu Y; Liu H; Xu J Cancer Sci; 2014 Nov; 105(11):1427-34. PubMed ID: 25155155 [TBL] [Abstract][Full Text] [Related]
11. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890 [TBL] [Abstract][Full Text] [Related]
12. GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma. Liu Y; Liu W; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J J Urol; 2014 Nov; 192(5):1534-41. PubMed ID: 24769034 [TBL] [Abstract][Full Text] [Related]
13. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma. Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921 [TBL] [Abstract][Full Text] [Related]
14. Notch1 predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection. An H; Zhu Y; Xu L; Chen L; Lin Z; Xu J Urology; 2015 Feb; 85(2):483.e9-483.e14. PubMed ID: 25559729 [TBL] [Abstract][Full Text] [Related]
15. High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma. NguyenHoang S; Liu Y; Xu L; Chang Y; Zhou L; Liu Z; Lin Z; Xu J Tumour Biol; 2016 Nov; 37(11):15193-15201. PubMed ID: 27683054 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival. Xu L; Zhu Y; An H; Liu Y; Lin Z; Wang G; Xu J Urol Oncol; 2015 Feb; 33(2):68.e9-16. PubMed ID: 25241276 [TBL] [Abstract][Full Text] [Related]
17. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma. An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847 [TBL] [Abstract][Full Text] [Related]
18. High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma. Yang Y; Zhai C; Chang Y; Zhou L; Shi T; Tan C; Xu L; Xu J Urol Oncol; 2016 May; 34(5):238.e19-26. PubMed ID: 26749463 [TBL] [Abstract][Full Text] [Related]
19. CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma. Wang Z; Xie H; Zhou L; Liu Z; Fu H; Zhu Y; Xu L; Xu J Oncotarget; 2016 Aug; 7(32):51525-51534. PubMed ID: 27409666 [TBL] [Abstract][Full Text] [Related]
20. P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma. Liu Z; Liu Y; Xu L; An H; Chang Y; Yang Y; Zhang W; Xu J Cancer Sci; 2015 Sep; 106(9):1224-31. PubMed ID: 26179886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]